ROLE OF COMPLEMENT IN ENDOTOXIC SHOCK
ROLE OF COMPLEMENT IN ENDOTOXIC SHOCK
批准号:
3837938
负责人:
C NATANSON
金额:
$0.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Studies of normal humans given a sublethal dose of endotoxin have shown
a cardiopulmonary response similar to the response of humans with septic
shock. This normal human model has been used in controlled
investigations to elucidate the pathophysiology of septic shock (N Engl
J Med 1989; 321:280).
Septic shock is a highly lethal disease (50-50% mortality) despite
optimal antibiotic and cardiovascular supportive therapy. Mortaity from
septic shock is caused by cardiovascular collapse or multiple organ
system failure. Sepsis is the most prevalent cause of death of patients
in intensive care units. Endotoxin, a component of the outer cell wall
of Gram-negative bacterial, is released into the circulation in patients
with septic shock and is thought to be the major pathogenic toxin.
During sepsis host cells release mediators in response to bacterial
toxins (endotoxin). These mediators produce the characteristic
cardiopulmonary response of sepsis and septic shock. The complement
system is a cascade of host mediators that are activated during sepsis
and may be beneficial or harmful to the host. If complement produces,
on balance, harmful effects during sepsis, antagonists to complement are
now available for humans and would be considered for therapy for septic
shock.
Brittany spaniels that are genetically deficient in the third component
of complement (C3) have been used in investigations of complement at
Johns Hopkins University. These dogs produce essentially no C3 (0.003%
of normal levels as determined by ELISA). They have normal levels of
other compement factors. C3 is required for activation of complement
components C5-C9 via classical and alternative pathways. Thus,
investigation of endotoxemia in these animals would clarify the
pathophysiologic role of complement.
This protocol proposes investigation of the effect of a sublethal
endotoxin infusion on C3 deficient Brittany spaniels. Because these
animals are difficult to breed and extremely scarce, there are a small
number of these valuable animal for investigation. In order to preserve
these animals, the dogs would be challenged with a sublethal dose of
endotoxin that produces cardiovascular profile similar to human septic
shock.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
USE OF A SELECTIVE BRADYKININ ANTAGONIST IN A CANINE MODEL OF SEPTIC SHOCK
-
批准号:5201091
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:C NATANSON
-
依托单位:
NITRIC OXIDE SYNTHASE INHIBITORS IN VIVO TNF-INDUCED MYOCARDIAL DEPRESSION
-
批准号:3752179
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:C NATANSON
-
依托单位:
INVESTIGATIONS OF NEW THERAPIES IN SEPTIC SHOCK
-
批准号:3874266
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:C NATANSON
-
依托单位:
A COMPARISON OF STRAINS OF E. COLI TO PRODUCE SEPTIC SHOCK IN DOGS
-
批准号:3853021
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:C NATANSON
-
依托单位:
ROLE OF COMPLEMENT IN ENDOTOXIC SHOCK
-
批准号:3774439
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:C NATANSON
-
依托单位:
MYOCARDIAL METABOLISM IN A CANINE MODEL OF HUMAN BACTERIAL SEPSIS
-
批准号:3774436
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:C NATANSON
-
依托单位:
A COMPARISON OF TWO STRAINS OF E COLI TO PRODUCE SEPTIC SHOCK IN DOGS
-
批准号:6161407
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:C NATANSON
-
依托单位:
INVESTIGATIONS OF NEW THERAPIES IN SEPTIC SHOCK
-
批准号:3896256
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:C NATANSON
-
依托单位:
CONTROLLED TRIAL OF TYROSINE KINASE INHIBITORS IN CANINE MODEL OF SEPTIC SHOCK
-
批准号:2456661
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:C NATANSON
-
依托单位:
CARDIOPULMONARY PATHOPHYSIOLOGY IN CANINE SEPTIC SHOCK
-
批准号:3916459
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:C NATANSON
-
依托单位:
A COMPARISON OF TWO STRAINS OF E COLI TO PRODUCE SEPTIC SHOCK IN DOGS
-
批准号:5201066
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:C NATANSON
-
依托单位:
A COMPARISON OF STRAINS OF E. COLI TO PRODUCE SEPTIC SHOCK IN DOGS
-
批准号:3837914
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:C NATANSON
-
依托单位:
INVESTIGATIONS OF NEW THERAPIES IN SEPTIC SHOCK
-
批准号:3752157
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:C NATANSON
-
依托单位:
BACTERICIDAL-PERMEABILITY INCREASING PROTEIN IN A CANINE MODEL OF SEPTIC SHOCK
-
批准号:3752182
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:C NATANSON
-
依托单位:
ROLE OF COMPLEMENT IN ENDOTOXIC SHOCK
-
批准号:3853060
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:C NATANSON
-
依托单位:
INVESTIGATIONS OF NEW THERAPIES IN SEPTIC SHOCK
-
批准号:3853034
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:C NATANSON
-
依托单位:
CATHECOLAMINE THERAPY IN CANINE SEPTIC SHOCK
-
批准号:3916437
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:C NATANSON
-
依托单位:
ENDOGENOUS MEDIATORS IN THE PATHOPHYSIOLOGY OF CANINE SEPTIC SHOCK
-
批准号:3916436
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:C NATANSON
-
依托单位:
CANINE MODEL OF SEPTIC SHOCK
-
批准号:3963111
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:C NATANSON
-
依托单位:
RECONSTITUTED HIGH-DENSITY LIPOPROTEINS IN A CANINE MODEL OF SEPTIC SHOCK
-
批准号:5201090
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:C NATANSON
-
依托单位:
国内基金
海外基金
Complement C6蛋白抑制DNA损伤修复增敏甲状腺乳头状癌放射性碘治疗的作用及其机制
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:刘宇佳
-
依托单位: